The Combination of Predictive Factors of Pharmacokinetic Origin Associates with Enhanced Disease Control during Treatment of Pediatric Crohn's Disease with Infliximab.

Dubinsky, Marla C; Rabizadeh, Shervin; Panetta, John C; Spencer, Elizabeth A; Everts-van der Wind, Annelie; Dervieux, Thierry

Dubinsky, Marla C; Rabizadeh, Shervin; Panetta, John C; Spencer, Elizabeth A; Everts-van der Wind, Annelie; Dervieux, Thierry.

Afiliação

Dubinsky MC; Mount Sinai Medical Center, New York, NY 10029, USA.
Rabizadeh S; Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
Panetta JC; St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Spencer EA; Mount Sinai Medical Center, New York, NY 10029, USA.
Everts-van der Wind A; Prometheus Laboratories, San Diego, CA 92121, USA.
Dervieux T; Prometheus Laboratories, San Diego, CA 92121, USA.

Pharmaceutics ; 15(10)2023 Sep 30.

Article em En | MEDLINE | ID: mdl-37896168

Palavras-chave

Crohn's disease; clearance; infliximab; pharmacokinetics; predictive factors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google